Titlebook: Controversies in the Anesthetic Management of the Obese Surgical Patient; Yigal Leykin,Jay B. Brodsky Book 2013 Springer-Verlag Italia 201

ineptitude

How Should You Manage Anti-Hypertensive Drugs in Morbidly Obese Surgical Patients? surgery?” requires rationale for why the drugs should be instituted or discontinued, and if their institution or discontinuation will improve or diminish chances for reduced morbidity and enhanced survival.

不可知論

NAIVE

Should Anesthesiologists Managing Morbidly Obese Patients Receive Special Education and Training?es in bariatric anesthesia nor are there mandatory rotations for residents by ACGME in dealing with morbidly obese patients. We present challenges in dealing with morbidly obese patients and propose a structured curriculum to train residents and/or trained anesthesiologists in dealing with morbidly obese patients.

商業(yè)上

How Should Obesity be Measured and How Should Anesthetic Drug Dosage be Calculated? to affect the pharmacokinetics and pharmacodynamics of anesthetic drugs. Rather than using weight-based measures of obesity, physicians need to look for methods of assessing adiposity that predict how dysmetabolic an obese individual actual is. Anesthesiologists need to use individualized dosing scalars to take into account these changes.

Mettle

Do All Morbidly Obese Patients Have a “Difficult” Airway?ficult airway management is indeed expected. In such patients, maximizing oxygenation is of primary importance. This chapter will therefore also highlight best practice in terms of preoxygenation and recruitment maneuvers which minimize atelectasis. Suggested alternatives to direct laryngoscopy that achieve rapid intubation will be recommended.

OUTRE

AMBI

https://doi.org/10.1007/978-88-470-2634-6Anesthesiology; Bariatric Surgery; Controversies in Management; Morbid Obesity; Pharmacology

肉身

978-88-470-5638-1Springer-Verlag Italia 2013

關節(jié)炎

巨碩

Vibronic Processes in Inorganic Chemistryity and body composition. Current medication dosage recommendations are usually based on weight alone and are intended for normal-weight individuals of varying size. Since drug dosage is based on total body weight, the changed body composition and pathophysiological alterations in obesity are likely